MitraClip registry for severe mitral valve leakage patients
Part of Heart & circulation clinical trials.
This registry study collects information on people with severe mitral valve leakage (regurgitation) who are treated with the MitraClip G4 device. It aims to better understand which patients benefit most and how well the procedure works in real-world care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have symptomatic severe mitral valve leakage (either “secondary” from heart strain or “degenerative/primary” from the valve itself)
- You are already on the best standard care (medicines and other needed treatments) before enrollment
- Your heart test results fit specific limits for heart size and pumping strength (for secondary cases) or valve shape measurements (for primary cases)
- You are not too sick right now (not hemodynamically unstable, and not NYHA class IV)
- You do not have key exclusions like severe right-heart failure, very high irreversible lung pressure, severe tricuspid leakage, active infection, or very limited life expectancy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry study follows people who have a severely leaky mitral heart valve and receive MitraClip, a procedure that repairs the valve through the skin. It helps doctors learn how well this treatment works over time for different patients.
This study is testing a new assist system to help doctors perform a minimally invasive procedure (MitraClip) that clips the leaky mitral valve without open-heart surgery. It is for people with severe mitral regurgitation who cannot safely have surgery or choose not to.
This trial tests if the MitraClip device helps people with heart failure and a leaky mitral valve. It uses a special MRI to check how the heart responds to treatment.
This study collects information from people treated with the MitraClip G5, a device that repairs a leaky mitral valve. It helps doctors learn more about how well the device works in real-world patients.
This trial tests a minimally invasive procedure to repair a leaky mitral valve in people with a specific type of heart failure. The goal is to see if the procedure, called transcatheter edge-to-edge repair (TEER), is safe and effective in reducing symptoms and improving heart function.
This trial tests a new catheter-based device to fix a leaky mitral valve without open-heart surgery. It is for people whose severe mitral regurgitation puts them at high risk for traditional surgery.
Hear when a new Mitral Valve Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.